Tolerance and Efficacy of Combined Nivolumab and Ipilimumab Following Monotherapy with PD-1 or CTLA-4 Blockade in Metastatic Melanoma

被引：0
|
作者：
Randhawa, M. [1 ]
Nguyen, B. [1 ]
Ali, S. [1 ,2 ]
Yip, D. [1 ,2 ]
机构：
[1] Canberra Hosp, Canberra, ACT, Australia
[2] Australian Natl Univ, Sch Med, Canberra, ACT, Australia
来源：
ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY | 2017年 / 13卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：71 / 71
页数：1
相关论文
共 50 条
  • [1] Comparative efficacy of combined CTLA-4 and PD-1 blockade vs. PD-1 monotherapy in metastatic melanoma: a real-world study
    Avital Klein-Brill
    Shlomit Amar-Farkash
    Keren Rosenberg-Katz
    Ronen Brenner
    Jürgen C. Becker
    Dvir Aran
    [J]. BJC Reports, 2 (1):
  • [2] Value of PD-L1, PD-1, and CTLA-4 Expression in the Clinical Practice as Predictors of Response to Nivolumab and Ipilimumab in Monotherapy in Patients With Advanced Stage Melanoma
    Santos-Briz, Angel
    Canueto, Javier
    Del Carmen, Sofia
    Barrios, Beatriz
    Yuste, Manuela
    Bellido, Lorena
    Dolores Ludena, Maria
    Roman, Concepcion
    [J]. AMERICAN JOURNAL OF DERMATOPATHOLOGY, 2021, 43 (06) : 423 - 428
  • [3] Successful Treatment of Myasthenia Gravis Following PD-1/CTLA-4 Combination Checkpoint Blockade in a Patient With Metastatic Melanoma
    Werner, Jan-Michael
    Schweinsberg, Viola
    Schroeter, Michael
    von Reutern, Boris
    Malter, Michael P.
    Schlaak, Max
    Fink, Gereon R.
    Mauch, Cornelia
    Galldiks, Norbert
    [J]. FRONTIERS IN ONCOLOGY, 2019, 9
  • [4] Prognostic factors and outcomes in metastatic uveal melanoma treated with PD-1 or combined PD-1 / CTLA-4 inhibition
    Heppt, M.
    Heinzerling, L.
    Kaehler, K.
    Forschner, A.
    Kirchberger, M.
    Loquai, C.
    Meissner, M.
    Meier, F.
    Terheyden, P.
    Schell, B.
    Herbst, R.
    Goeppner, D.
    Kiecker, F.
    Rafei-Shamsabadi, D.
    Haferkamp, S.
    Huber, M.
    Utikal, J.
    Ziemer, M.
    Bumeder, I
    Pfeiffer, C.
    Schd-Trcka, S.
    Schmid-Tannwald, C.
    Tietze, J.
    Eigentler, T.
    Berking, C.
    [J]. JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, 2017, 15 : 14 - 14
  • [5] PD-1 checkpoint blockade alone or combined PD-1 and CTLA-4 blockade as immunotherapy for lung cancer?
    Tanvetyanon, Tawee
    Gray, Jhanelle E.
    Antonia, Scott J.
    [J]. EXPERT OPINION ON BIOLOGICAL THERAPY, 2017, 17 (03) : 305 - 312
  • [6] MHC proteins confer differential sensitivity to CTLA-4 and PD-1 blockade in untreated metastatic melanoma
    Rodig, Scott J.
    Gusenleitner, Daniel
    Jackson, Donald G.
    Gjini, Evisa
    Giobbie-Hurder, Anita
    Jin, Chelsea
    Chang, Han
    Lovitch, Scott B.
    Horak, Christine
    Weber, Jeffrey S.
    Weirather, Jason L.
    Wolchok, Jedd D.
    Postow, Michael A.
    Pavlick, Anna C.
    Chesney, Jason
    Hodi, F. Stephen
    [J]. SCIENCE TRANSLATIONAL MEDICINE, 2018, 10 (450)
  • [7] Multiomic meta-analysis of differential response to PD-1 and CTLA-4 blockade in metastatic melanoma
    Huang, Amy Y.
    Vokes, Natalie
    Ricker, Cora
    Aprati, Tyler
    Robitschek, Emily
    Yang, Jiekun
    Ho, Li-Lun
    Galani, Kyriakitsa
    Burke, Kelly P.
    Tarantino, Giuseppe
    Chen, Jiajia
    Sharpe, Arlene H.
    Van Allen, Eliezer M.
    Kellis, Manolis
    Boland, Genevieve M.
    Liu, David
    [J]. CANCER RESEARCH, 2023, 83 (07)
  • [8] Molecular and immune predictors of response and toxicity to combined CTLA-4 and PD-1 blockade in metastatic melanoma (MM) patients (pts).
    Chen, Wei-Shen
    Cameron, Miles
    Spencer, Christine
    Tawbi, Hussein Abdul-Hassan
    Lazar, Alexander
    Tetzlaff, Michael T.
    Patel, Sapna Pradyuman
    Hwu, Patrick
    Hwu, Wen-Jen
    Diab, Adi
    Glitza, Isabella Claudia
    Amaria, Rodabe Navroze
    Burton, Elizabeth M.
    Woodman, Scott Eric
    Davies, Michael A.
    Gershenwald, Jeffrey E.
    Sharma, Padmanee
    Allison, James Patrick
    Futreal, Andrew
    Wargo, Jennifer Ann
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [9] Radiation necrosis with stereotactic radiosurgery combined with CTLA-4 blockade and PD-1 inhibition for treatment of intracranial disease in metastatic melanoma
    Fang, Penny
    Jiang, Wen
    Allen, Pamela
    Glitza, Isabella
    Guha, Nandita
    Hwu, Patrick
    Ghia, Amol
    Phan, Jack
    Mahajan, Anita
    Tawbi, Hussein
    Li, Jing
    [J]. JOURNAL OF NEURO-ONCOLOGY, 2017, 133 (03) : 595 - 602
  • [10] Radiation necrosis with stereotactic radiosurgery combined with CTLA-4 blockade and PD-1 inhibition for treatment of intracranial disease in metastatic melanoma
    Penny Fang
    Wen Jiang
    Pamela Allen
    Isabella Glitza
    Nandita Guha
    Patrick Hwu
    Amol Ghia
    Jack Phan
    Anita Mahajan
    Hussein Tawbi
    Jing Li
    [J]. Journal of Neuro-Oncology, 2017, 133 : 595 - 602
12345